Barrow, Hanley, Mewhinney & Strauss
DVAX

Barrow, Hanley, Mewhinney & Strauss’s Dynavax Technologies DVAX Stock Holding History

Barrow, Hanley, Mewhinney & Strauss’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-779
Closed -$9.95K – 329
2024
Q4 		$9.95K Hold
779
– – ﹤0.01% 229
2024
Q3 		$8.68K Buy
+779
New +$8.59K ﹤0.01% 237

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss's DVAX Position: Q1 2025 in Review

Barrow, Hanley, Mewhinney & Strauss sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 779 shares — an estimated $9.95K sold.

Barrow, Hanley, Mewhinney & Strauss first reported a position in DVAX in Q3 2024 and held it in 2 quarters. The position peaked at $9.95K in Q4 2024. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Barrow, Hanley, Mewhinney & Strauss reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Barrow, Hanley, Mewhinney & Strauss sold 779 Dynavax Technologies shares in Q1 2025, an estimated $9.95K.
  • Barrow, Hanley, Mewhinney & Strauss first reported a position in Dynavax Technologies in Q3 2024 and held it in 2 quarters.
  • Barrow, Hanley, Mewhinney & Strauss's Dynavax Technologies position peaked at $9.95K in Q4 2024.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2025, filed 12 May 2025.